Experts for Media - Cancer - Adult Oncology
Home > .Newsroom > Experts for Media  > Experts for Media - Landing Page > Experts for Media - Cancer - Adult Oncology
Print

.Newsroom

Experts for Media - Cancer - Adult Oncology

Shalom Kalnicki, MD

Chairman, Department of Radiation Oncology, Montefiore Medical Center

Professor, Department of Radiation Oncology, Albert Einstein College of Medicine

Dr. Kalnicki focuses on researching and implementing new technologies in the radiation treatment of cancer, with the aim of enhancing the dose to the tumor target while preserving normal tissues from radiation injury, potentially increasing tumor control and improving quality of life. His research has implications for radiation treatment planning and techniques used for most clinical situations in radiation oncology, including brain, head and neck, thoracic, upper abdominal and pelvic malignancies.

Areas of Expertise

  • IMRT
  • IGRT
  • Tumor imaging with PET/CT fusion techniques
  • Radiation therapy for head and neck cancers, prostate cancer, and breast cancer

Selected Media Coverage

New York Times

Roman Perez-Soler, MD

Chairman, Department of Oncology, Montefiore Medical Center

Chief, Medical Oncology, Montefiore Medical Center

Professor, Department of Medicine (Oncology), Albert Einstein College of Medicine

Professor, Department of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine

Dr. Perez-Soler’s interest focuses on lung cancer and the development of inhalational therapeutics for treatment of this disease. He is a leading researcher in liposomal drug delivery with over 20 years’ experience in this area. Dr. Perez-Soler’s investigations have examined the development of liposomal platinum, anthracycline and retinoic acid antineoplastic compounds. He has received numerous awards for his accomplishments, particularly in lung cancer research, and is considered an international cancer expert in experimental cancer therapy.

Areas of Expertise

  • Lung cancer
  • Inhalation therapy
  • Medical oncology
  • Experimental cancer therapies

Selected Media Coverage

HealthDay News, Wall Street Journal, Onclive.com

Mark Schoenberg, MD

Chair, Department of Urology and Division of Urologic Oncology, MECCC and Einstein, Professor of Urology

Dr. Schoenberg is a leader in new therapies and advanced surgical and non-surgical treatments for all forms of bladder cancer. His research focuses on the translational validation of urinary markers for the early detection of cancer. He also concentrates on the development of regenerative medicine to improve lower urinary tract reconstruction after bladder removal surgery.

Areas of Expertise

  • Clinical milestones in bladder cancer treatment
  • Vaginal and pelvic floor reconstruction

Chandan Guha, MB, BS, PhD

Vice Chairman, Radiation Oncology, Montefiore Medical Center

Professor, Department of Pathology, Albert Einstein College of Medicine

Dr. Guha is a radiation oncologist who specializes in prostate, genitourinary, liver and GI malignancies, and radiosurgery. His research interests include development of stem-cell based therapies to treat radiation-induced toxicity and prevent death in patients.

Areas of Expertise

  • Targeted delivery of chemotherapy and immunotherapies for cancer
  • Cancer radiation treatment dosage and standards

Richard V. Smith, MD

Vice Chairman, Department of Otorhinolaryngology-Head and Neck Surgery, Director, Head and Neck Service, Montefiore Medical Center

Professor of Pathology and Surgery and Co-Director, Upper Aerodigestive Tract Research Group, Albert Einstein College of Medicine

Dr. Smith's areas of expertise include Head and Neck Cancer Surgery, Robotic Head and Neck Surgery, Thyroid and Parathyroid Surgery, Salivary Gland Surgery, Minimally Invasive Head and Neck Surgery. His research focus is on identifying genetic and biologic aspects of head and neck cancer which correlate with a patient’s prognosis, the goal of which is to help determine the optimal treatment for an individual patient to maximize their chance of cure and minimize treatment related side effects.

Areas of Expertise

  • Surgical treatment of head and neck cancers
  • Robotic head and neck surgery
  • Minimally invasive head and neck surgery
  • Thyroid and parathyroid surgery

Selected Media Coverage

NY Daily News

Joseph Sparano, MD, FACP

Associate Chairman of Oncology, Montefiore Medical Center

Professor, Department of Medicine, Albert Einstein College of Medicine

Professor, Department of Obstetrics, Gynecology, & Women’s Health, Albert Einstein College of Medicine

Dr. Sparano is a media oncologist specializing in clinical and translational cancer reasearch. His research has focused on developmental theapeutic approaches for breast cancer, lymphoma, and HIV-associated cancers, and therapeutic application of molecular profiling in cancer.

He serves as Vice Chair of the ECOG-ACRIN Research Group and Vice Chair of the AIDS Malignancy Consortium. He is co-principal investigator of the Montefiore-Einstein Minority/Underserved National Community Oncology Research Program (NCORP) grant (in conjunction with Dr. Bruce Rapkin), which funds multicenter, NCI-sponsored clinical trials in cancer therapeutics, cancer prevention/control, and cancer care delivery research. He is also the recipient of funding from the Breast Cancer Research Foundation that is supporting creation of a biospecimen bank designed to identify determinants of late relapse.

Areas of Expertise

  • Breast cancer disparities
  • Lymphoma
  • HIV- associated cancer
  • Breast cancer disparities
  • Obesity’s link to cancer
  • Phase I-III clinical trials
  • Clinical application of genomic profiling
  • Recruiting minorities into clinical trials
  • Latest breast cancer research and diagnostic tools

Selected Media Coverage

New York Times, Science Daily, The Wall Street Journal, WBAL-TV, ASCO Post, ASCO Post, Montefiore

Sheldon Feldman, MD

Chief, Division of Breast Surgery and Surgical Oncologya nd Director, Breast Cancer Services, MECCC; Professor of Clinical Surgery, Albert Einstein College of Medicine

Dr. Feldman leads the breast surgery and breast surgical oncology program at Montefiore. Since 2003, he has been recognized annually as one of New York Metro Area's Top Doctors and since 2004, he has also been included in the annual "Guide to America's Top Surgeons."

Dr. Feldman is a recogized leader in the develpment of innovative minimally invasive techniques to diagnose breast cancer. He has also led extensive research into the causes of breast cancer with the goal of being able to diagnose earlier and more effectively. Since 2007, he has been the principal investigator of the Breast Cancer Pesticle Study to measure pesticide and PCB levels in breast tissue and blood in 200 participants.

Areas of Expertise

  • New surgical and minimally invasive breast cancer treatments
  • Lymphedema expert
  • Skin-sparing and nipple-preserving mastectomies
  • Clinical trials focused on the application of ductoscopy for the imaging, diagnosis and treatment of patients with ductal carcinoma, the most common type of breast cancer.

Selected Media Coverage

Associated Press 

Peter Shamamian, MD

Chief, Division of General Surgery, Montefiore Medical Center

Director, Pancreas and Upper Gastrointestinal Surgery, Montefiore Medical Center

Professor of Clinical Surgery, Albert Einstein College of Medicine

Dr. Shamamian is a clinical specialist and researcher in pancreatic diseases. His areas of expertise include pancreatitis (acute and chronic) and pancreatic neoplasms (benign and malignant). He has a special interest in minimally-invasive and laparoscopic operative alternatives to treat these diseases.

Areas of Expertise

  • Pancreatitis
  • Pancreatic tumors (benign and malignant)

 

Fernando Camacho, MD

Fernando J. Camacho, MD

Director, Community Oncology, Montefiore Einstein Center for Cancer Care
Attending Physician & Clinical Assistant Professor, Bronx River Medical Associates Oncology/Hematology of Montefiore Medical Center

Fernando J. Camacho, M.D., director of Community Oncology at Montefiore Einstein Center for Cancer Care (MECCC), is an accomplished medical oncologist with more than 30 years of experience serving minority and medically underserved communities. He specializes in addressing the barriers that prevent oncology and benign hematology patients and families from accessing quality healthcare. The mission of the Community Oncology program is to provide access to preventative and state of the art cancer care and research through education, community outreach and physician engagement.

Areas of Expertise

  • Fluent in Spanish
  • Health disparities in oncology
  • Access to clinical research for minorities
  • Solid tumors and hematological malignancies

Selected Media Coverage

News 12 – Bronx, BronxNet TV

David Geller, MD

Director, Sarcoma and Soft-Tissue Oncology Service, Montefiore Medical Center

Assistant Professor, Orthopaedic Surgery, Albert Einstein College of Medicine

Assistant Professor, Pediatrics (Hematology & Oncology), Albert Einstein College of Medicine

Dr. Geller is an orthopaedic surgeon specializing in musculoskeletal oncology and joint replacement, and his practice encompasses adult and pediatric patients. Dr. Geller’s research interests include surface receptor expression in osteosarcoma and potential targeted therapies for the treatment of osteosarcoma. He has developed a novel murine xenograft model for osteosarcoma for the evaluation of surgical margins in osseous tumor surgery. His research additionally includes allograft bone reconstruction techniques, resonance frequency changes during joint reconstruction and pain management in the elderly orthopaedic population.

Areas of Expertise

  • Musculoskeletal oncology and joint replacement (adult and pediatric).
  • Innovative surgical treatments and patient-tailored implants for those who suffer from osteosarcoma and other primary bone tumors
  • Limb sparing surgical techniques

Selected Media Coverage

NY Daily News, Montefiore

Alyson Moadel, PfhD

Director, Psychosocial Oncology Program, Albfert Einstein Cancer Center

Associate Professor, Clinical Epidemiology & Population Health, Albert Einstein College of Medicine

Associate Professor, Clinical Medicine, Albert Einstein College of Medicine

Dr. Moadel is a health psychologist who leads programs designed to help patients and their families cope with the psychological and emotional effects of cancer and cancer treatment. Her Bronx Oncology Living Daily (B.O.L.D. Living) program, sponsored by a grant from the Entertainment Industry Foundation’s Revlon Run/Walk, offers a variety of free support, educational, and mind-body workshops designed to empower and nurture cancer patients, survivors, and loved ones. Workshops feature fitness/nutrition, mind-body programs, creative arts and more.

Areas of Expertise

  • Psychosocial support for adult cancer patients
  • Emotionally and mentally preparing for cancer treatments and survivorship
  • Novel support programs for those impacted by cancer and tips for patients and loved ones on how to cope with the disease
  • Research on cancer management (e.g. impact of yoga of cancer survivorship)

Selected Media Coverage

CBS News, Women's Health Magazine, U.S. News & World Report, Einstein

Ira Braunschweig, MD

Clinical Program Director, Hematologic Malignancies, Montefiore Einstein Center for Cancer Care and Associate Professor of Clinical Medicine, Department of Medicine (Oncology) at Albert Einstein College of Medicine

Dr. Braunschweig is the Director of the Stem Cell Transplant Program and the Clinical Program Director of Hematologic Malignancies at Montefiore. Starting at Mentefiore in March 2003, Dr. Braunschweig has built the Stem Cell Transplant program into a high volume program recognized by the highest cellular therapy governing organization (Foundation for the Accreditation of Cellular Therapy or FACT).

His interests include the treatment of acute leukemias, lymphoma and multiple myeloma, especially using stem cell transplant as a platform for immunotherapy to treat these disorders.

Areas of Expertise

  • Blood cancer research and treatment
  • Innovative clinical trials, CAR-T therapy, cell transfer therapies

Selected Media Coverage

Healio